Valuation: Carmat SA

Market Cap 61.46L 69.87L 57.94L 52.86L 98.85L 67Cr 99.62L 6.95Cr 2.69Cr 34Cr 2.62Cr 2.57Cr 111.08Cr P/E 2023
-3.09x
P/E 2024 -0.95x
Enterprise Value 5.92Cr 6.74Cr 5.59Cr 5.1Cr 9.53Cr 646.56Cr 9.6Cr 67Cr 26Cr 329.06Cr 25Cr 25Cr 1.07TCr EV / Sales 2023
56.1x
EV / Sales 2024 13.5x
Free-Float
89.06%
Yield 2023 *
-
Yield 2024 -
Current year 0.1
Extreme 0.099
0.1
1 year 0.1
Extreme 0.099
0.1
3 years 0.08
Extreme 0.085
9.99
5 years 0.08
Extreme 0.085
30.25
10 years 0.08
Extreme 0.085
40.06
Manager TitleAgeSince
Chief Executive Officer 55 01/09/2016
Director of Finance/CFO - 12/12/2018
Chief Tech/Sci/R&D Officer - 01/04/2025
Director TitleAgeSince
Director/Board Member 55 -
Director/Board Member 68 02/01/2017
Director/Board Member 79 20/04/2017
Date Insider Type Main position Quantity % Market Cap. Importance
13/03/25 Sell

Chairman

13,43,333 2.3347%
13/03/25 Buy

Chairman

13,43,333 2.3347%
29/05/24 Buy

Director

13,43,333 4.6122%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-.--%-98.67% 70.8L
-1.34%-3.71%-27.33%-5.44% 10TCr
-0.30%-2.99%-24.73%-3.27% 1.12TCr
+0.91%-4.05%+87.08%+105.74% 904.91Cr
-1.29%+3.90%-49.08%-66.54% 419.8Cr
-0.91%+6.85%-24.92%+29.07% 251.37Cr
-0.36%-5.40%-11.59%-62.81% 199.66Cr
-3.28%+5.47% - - 200.57Cr
-1.43%+1.02%-22.05%-27.50% 155.28Cr
Average -0.89%-0.65%-9.08%-16.18% 1.53TCr
Weighted average by Cap. -1.11%-3.20%-19.81%-0.19%

Financials

2023 2024
Net sales 38.37L 43.62L 36.17L 33L 61.72L 42Cr 62.2L 4.34Cr 1.68Cr 21Cr 1.64Cr 1.6Cr 69Cr 73.44L 83.49L 69.23L 63.16L 1.18Cr 80Cr 1.19Cr 8.31Cr 3.22Cr 41Cr 3.13Cr 3.07Cr 132.74Cr
Net income -5.39Cr -6.12Cr -5.08Cr -4.63Cr -8.66Cr -587.88Cr -8.73Cr -61Cr -24Cr -299.2Cr -23Cr -22Cr -973.63Cr -5.14Cr -5.84Cr -4.84Cr -4.42Cr -8.27Cr -560.88Cr -8.33Cr -58Cr -23Cr -285.46Cr -22Cr -21Cr -928.91Cr
Net Debt 4.96Cr 5.64Cr 4.68Cr 4.27Cr 7.98Cr 541.69Cr 8.05Cr 56Cr 22Cr 275.69Cr 21Cr 21Cr 897.12Cr 5.31Cr 6.04Cr 5.01Cr 4.57Cr 8.54Cr 579.49Cr 8.61Cr 60Cr 23Cr 294.93Cr 23Cr 22Cr 959.73Cr
Logo Carmat SA
Carmat SA, formerly known as Carmat SAS is a France-based company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. It specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.
Employees
153
  1. Stock Market
  2. Stocks
  3. ALCAR Stock